Publications by authors named "Michael Shultz"

Claim this Profile
T
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 Agonists.
Christopher G Thomson, Kelly Boss, Amy Calhoun, Cary Fridrich, Kevin M Gardinier, Michael D Shultz

ACS Med Chem Lett· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Novartis' Small Molecule Screening Deck Design.
Ansgar Schuffenhauer, Nadine Schneider, Samuel Hintermann, Douglas Auld, Jutta Blank, Michael D Shultz

J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.
Matthew J LaMarche, Michael Acker, Andreea Argintaru, Daniel Bauer, Julie Boisclair, Michael D Shultz

J Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Shock Index is not accurate at predicting outcomes in patients with upper gastrointestinal bleeding.
Eliana Saffouri, Clare Blackwell, Stig B Laursen, Loren Laine, Harry R Dalton, Michael Shultz

Aliment Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.
Jeffrey T Bagdanoff, Zhouliang Chen, Michael Acker, Ying-Nan Chen, Homan Chan, Michael D Shultz

J Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to 6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors.
Patrick Sarver, Michael Acker, Jeffrey T Bagdanoff, Zhouliang Chen, Ying-Nan Chen, Michael D Shultz

J Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs.
Michael D Shultz

J Med Chem· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Allosteric Inhibition of SHP2 Phosphatase.
Michelle Fodor, Edmund Price, Ping Wang, Hengyu Lu, Andreea Argintaru, Michael David Shultz

ACS Chem Biol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Color, Multiplex Analysis of Protein Microarrays for Precision Medicine.
Solomon Yeon, Florian Bell, Michael Shultz, Grace Lawrence, Michael Harpole

Methods Mol Biol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor.
Young Shin Cho, Julian R Levell, Gang Liu, Thomas Caferro, James Sutton, Michael Shultz

ACS Med Chem Lett· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.
Ying Huang, Jeff Zhang, Zhengtian Yu, Hailong Zhang, Youzhen Wang, Michael D Shultz

J Med Chem· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase.
Andreas Lingel, Martin Sendzik, Ying Huang, Michael D Shultz, John Cantwell

J Med Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis.
Brian A Shapiro, Ngoc T Vu, Michael D Shultz, Jacqueline C Shultz, Jennifer A Mietla

J Biol Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone Deacetylase Inhibitors Prolong Cardiac Repolarization through Transcriptional Mechanisms.
Stan Spence, Mark Deurinck, Haisong Ju, Martin Traebert, LeeAnne McLean, Michael Shultz

Toxicol Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor.
Jorge Garcia Fortanet, Christine Hiu-Tung Chen, Ying-Nan P Chen, Zhouliang Chen, Zhan Deng, Michael D Shultz

J Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
Ying-Nan P Chen, Matthew J LaMarche, Ho Man Chan, Peter Fekkes, Jorge Garcia-Fortanet, Michael D Shultz

Nature· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspase-9b Interacts Directly with cIAP1 to Drive Agonist-Independent Activation of NF-κB and Lung Tumorigenesis.
Ngoc T Vu, Margaret A Park, Michael D Shultz, Gamze B Bulut, Amy C Ladd

Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ventricular ectopic burden in a premature ventricular contraction-induced cardiomyopathy animal model.
Alex Y Tan, Yuhning L Hu, Jonathan Potfay, Karoly Kaszala, Maureen Howren, Michael Shultz

Heart Rhythm· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Seed Growth of Iron Oxide Nanoparticles in Benzyl Alcohol - Optimization for Heating and Broad Stability in Biomedical Applications.
Stanley E Gilliland, Everett E Carpenter, Michael D Shultz

Nanobiomedicine (Rij)· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the plausibility of success with inefficient metrics.
Michael D Shultz

ACS Med Chem Lett· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters.
Michael D Shultz

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations.
Michael D Shultz

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metallofullerenes: a new class of MRI agents and more?
Panos P Fatouros, Michael D Shultz

Nanomedicine (Lond)· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases.
Michael D Shultz, Dyuti Majumdar, Donovan N Chin, Pascal D Fortin, Yun Feng

J Med Chem· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor.
Michael D Shultz, Atwood K Cheung, Christina A Kirby, Brant Firestone, Jianmei Fan

J Med Chem· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis